References
- GLOBOCAN 2012: Stomach Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012 [cited 2017 Dec 13]. Available from: http://globocan.iarc.fr/old/FactSheets/cancers/stomach-new.asp
- National Comprehensive Cancer Network. Gastric Cancer (Version 5. 2017) [cited 2017 Dec 13]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf
- Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38–v49..
- Allum WH, Blazeby JM, Griffin SM, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60:1449–1472.
- De Manzoni G, Marrelli D, Baiocchi GL, et al. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer. 2017;20:20–30.
- Schwartz AL, Landon BE, Elshaug AG, et al. Measuring low-value care in Medicare. JAMA Intern Med. 2014;174:1067–1076.
- Rubin GD, McNeil BJ, Palko A, et al. External factors that influence the practice of radiology: proceedings of the international society for strategic studies in radiology meeting. Radiology. 2017;283:845–852.
- Morden NE, Colla CH, Sequist TD, et al. Choosing wisely–the politics and economics of labeling low-value services. N Engl J Med. 2014;370:589–592..
- Lim JS, Yun MJ, Kim MJ, et al. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2006; 26:143–156.
- Kim KA, Park CM, Park SW, et al. CT findings in the abdomen and pelvis after gastric carcinoma resection. Am J Roentgenol. 2002;179:1037–1041.
- Gore RM. Gastric cancer. Clinical and pathologic features. Radiol Clin North Am. 1997;35:295–310.
- Gold JS, Jaques DP, Bentrem DJ, et al. Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. Ann Surg Oncol. 2007;14:365–372.
- Rosa F, Marrelli D, Morgagni P, et al. Krukenberg tumors of gastric origin: the rationale of surgical resection and perioperative treatments in a multicenter western experience. World J Surg. 2016;40:921–928.
- Wang J, Shi YK, Wu LY, et al. Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer. 2008;18:825–832.
- Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6–22.
- Wang Z, Chen J-Q. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol. 2011;11:19.
- Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–2481.
- Rubin GD. Costing in radiology and health care: rationale, relativity, rudiments, and realities. Radiology. 2017;282:333–347.
- Gollub MJ, Lefkowitz R, Moskowitz CS, et al. Pelvic CT in patients with esophageal cancer. Am J Roentgenol. 2005;184:487–490.
- Fielding JR, Aliabadi N, Renshaw AA, et al. Staging of 119 patients with renal cell carcinoma: the yield and cost-effectiveness of pelvic CT. Am J Roentgenol. 1999;172:23–25.
- Bailey JJ, Ellis JH, Davenport MS, et al. Value of pelvis CT during follow-up of patients with pancreatic adenocarcinoma. Abdom Radiol. 2017;42:211–215.